Bang Wonseok, You Heejeong, Park Jong-Moon, Park Junyoung, Kang Byeongsoo, Ju Minjung, Park Yelin, Lee Hookeun, Back Seunghoon, Lew Helen
Basil Biotech, Incheon 21984, Republic of Korea.
College of Pharmacy, Gachon University, Incheon 21936, Republic of Korea.
Int J Mol Sci. 2025 Jul 4;26(13):6449. doi: 10.3390/ijms26136449.
The pathogenesis of primary acquired nasolacrimal duct obstruction (PANDO) remains unclear, with several factors implicated, including anatomical structures, hormones, and tear components. This study explored tear proteins to better understand PANDO etiology by comparing protein expression in tears from patients with PANDO and healthy controls. Tear samples were collected from 22 patients with PANDO (mucous and membranous types) and 8 controls using Weck-Cel sponges. Protein analysis was conducted using LC-MS/MS to identify and quantify tear proteins. Female patients with PANDO had higher numbers of differentially expressed proteins (DEPs) compared with males. Certain DEPs associated with inflammatory pathways or the lacrimal duct epithelium, including SERPINB1, SERPINA3, CTSG, SLPI, and EZR, were identified in male patients. Although this is a preliminary study, our results offer insights into the pathogenesis of PANDO, with potential to distinguish between mucous and membranous subtypes. The potential biomarkers identified in this study could enhance early diagnosis and treatment, shedding light on inflammatory and immune processes in PANDO.
原发性获得性鼻泪管阻塞(PANDO)的发病机制尚不清楚,涉及多种因素,包括解剖结构、激素和泪液成分。本研究通过比较PANDO患者和健康对照者泪液中的蛋白质表达,探索泪液蛋白质以更好地了解PANDO的病因。使用Weck-Cel海绵从22例PANDO患者(黏液型和膜型)和8例对照者中收集泪液样本。使用液相色谱-串联质谱法(LC-MS/MS)进行蛋白质分析,以鉴定和定量泪液蛋白质。与男性相比,PANDO女性患者的差异表达蛋白(DEP)数量更多。在男性患者中鉴定出某些与炎症途径或泪管上皮相关的DEP,包括丝氨酸蛋白酶抑制剂B1(SERPINB1)、丝氨酸蛋白酶抑制剂A3(SERPINA3)、组织蛋白酶G(CTSG)、分泌性白细胞蛋白酶抑制剂(SLPI)和埃兹蛋白(EZR)。尽管这是一项初步研究,但我们的结果为PANDO的发病机制提供了见解,有可能区分黏液型和膜型亚型。本研究中鉴定出的潜在生物标志物可加强早期诊断和治疗,为PANDO中的炎症和免疫过程提供线索。